Sunday, February 15

IonQ Stock Falls 2.5% This Week on Short-Seller Report and Legal Probe Converge


  • IonQ (IONQ) shares fell 2.5% last week, but a rally on Friday was welcome relief to shareholders that have been battered by selling since mid-October.

  • IonQ’s $1.8B acquisition of SkyWater Technology (SKYT) in late January hasn’t stemmed losses as shares have declined 27% since.

  • Wall Street remains bullish on the company, but expectations to deliver revenue growth are growing as the market sours on momentum stocks.

  • A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here.

IonQ Inc (NYSE:IONQ) dropped 2.5% this week, underperforming both the SPDR S&P 500 ETF Trust (NYSEARCA:SPY)’s 1.3% decline and the Invesco QQQ Trust (NASDAQ:QQQ)’s 1.3% drop. The bad news? Shares were down. The good news? Friday saw a welcome relief rally of 9%.

Shares opened the day largely flat, but rallied into noon. IonQ shares are still down signficantly from their 52-week highs, but the company is outperforming many of its quantum peers despite the drop.

Three distinct storylines collided this week: a controversial short-seller attack, a massive acquisition that spooked investors, and a widening gap between analyst optimism and market reality.

IonQ closed at $34.11 on Friday, extending year-to-date losses to 24%.

The stock now trades 33% below where it started 2026, a sharp reversal from its five-year run that’s still up 189%. The weakness accelerated through February, with shares down 33% over the past month. That volatility aligns with IonQ’s beta of 2.6, meaning the stock moves more than twice as much as the broader market.

Overall, the market’s monetum sell-off that began in mid-October has continued into 2026. It’s a tough environment for companies selling at high price to sales multiples and will demand more tangible results across the next two years if IONQ is going to break out of the negative sentiment surrounding the stock today.

On February 6, Wolfpack Research released a report questioning IonQ’s revenue methodology and dependency on U.S. defense funding. The stock dropped approximately 11% following the release.

The report alleged the company lost funding for key Pentagon contracts and improperly reported bookings. Within hours, law firm Ademi LLP announced a securities fraud investigation focusing on whether revenues were inflated by federal government backdoor earmarks and whether executives’ nearly $400 million in stock sales constituted insider trading.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *